Transcranial Magnetic Stimulation for Depression: Not so Effective, but FDA Approved
Apparently, the FDA will approve just about anything as an antidepressant. Despite patients indicating that they don't perceive Abilify to work as an antidepressant, the FDA approved it, likely leading to tens of thousands of Americans being able to enjoy a taste of akathisia while getting all the psychological benefits of a placebo. Good work, FDA. The shift of anti

Lend Me Your Name
Journalism regarding the horrors of ghostwritten papers in medical journals is all the rage these days (1, 2, 3). Here's my very small contribution. The document shown below from a medical writing company has been described elsewhe

Wanted: Drug Pimp/Key Opinion Leader
Daniel Carlat from the Carlat Psychiatry Blog received an invitation to the key opinion leader club from the good people at Schering-Plough. The company wanted him to read their slides to other physicians in order to promote their brand spanikn' new antipsychotic/mood stabilizer Saphris (asenapine). Because, of course, if he reads the slides, they are more credible than if read by one of those sleazy drug reps; it's so much more classy and believ

Key Opinion Leader Syndrome
I ran across a rather hilarious article from Medical Hypotheses, in which David Healy described "Krapelin-Fraud Syndrome", which I have also dubbed "Key Opinion Leader Syndrome." See below for the diagnostic criteria.In line with current neo-Kraepelinian thinking, we put forward operational criteria f